Abeona Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ABEO Nasdaq 8731 https://abeonatherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Abeona Therapeutics Inc

Aerie (AERI) Starts Late-Stage Study to Treat Dry Eye Disease - May 25th, 2022 6:29 pm
Athersys (ATHX) Down as Ischemic Stroke Study Fails to Meet Goal - May 23rd, 2022 7:32 pm
Enanta's (ENTA) RSV Drug Fails to Meet Study Goal, Stock Drops - May 19th, 2022 7:02 pm
Abeona Therapeutics Granted Second 180-Day Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule - May 19th, 2022 11:30 am
AVROBIO (AVRO) Stock Up on Upbeat Data From Cystinosis Study - May 18th, 2022 7:12 pm
Ultragenyx (RARE) Acquires Rights of AAV Gene Therapy Candidate - May 18th, 2022 3:47 pm
AbbVie (ABBV) Buys Option Rights to NextGen Inflammation Drug - May 17th, 2022 1:27 pm
Ultragenyx Acquires Global Rights to AAV Gene Therapy ABO-102 for Sanfilippo Syndrome Type A (MPS IIIA) from Abeona Therapeutics - May 17th, 2022 12:00 pm
Abeona Therapeutics Reports First Quarter 2022 Financial Results - May 13th, 2022 11:30 am
AbbVie's (ABBV) Rinvoq Meets Crohn's Disease Study Goals - May 12th, 2022 6:47 pm
Epizyme (EPZM) Q1 Earnings Miss, Revenues Lag Estimates - May 11th, 2022 6:28 pm
Amicus (FOLD) Q1 Earnings Miss, Galafold Sales Top Estimates - May 10th, 2022 6:36 pm
Bausch (BHC) Q1 Earnings and Revenues Miss, Stock Down - May 10th, 2022 3:37 pm
Aerie (AERI) Q1 Loss Wider Than Expected, Revenues Rise Y/Y - May 6th, 2022 7:48 pm
ChemoCentryx (CCXI) Q1 Earnings and Sales Miss Estimates - May 6th, 2022 7:38 pm
Abeona Therapeutics Announces AAV204, a Novel AAV Capsid, Demonstrated Robust Macular Transduction Following Para-Retinal Administration in Non-Human Primates - May 4th, 2022 11:30 am
Dianthus, a new $100M startup, aims to make autoimmune treatments easier - May 3rd, 2022 11:00 am
Abeona Therapeutics Announces Presentation at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting - Apr 29th, 2022 1:00 pm
Abeona Therapeutics Announces Pricing of $25 Million Private Placement of Convertible Redeemable Preferred Stock - Apr 29th, 2022 11:30 am
Can Abeona Therapeutics (NASDAQ:ABEO) Afford To Invest In Growth? - Apr 19th, 2022 2:51 pm